h05 — Calcium Oscillation Acoustic Therapy
mech. Chronic acoustic stimulation at 45-60 dB LAeq drives AC1-CREB Ca2+ oscillations, upregulating endogenous STRC expression via maternal E1659A allele. delivery. Hearing aid or Touch Grass app; non-invasive, zero delivery risk. patient-fit. Maternal allele only (E1659A contributes 0.5 dose); affinity penalty likely 10-100x puts rescue outside feasibility window.
status
A-tier. next: SPR/BLI measurement of E1659A TMEM145 affinity penalty (wet-lab gate).
Recent activity
const p = dv.page(dv.current().file.folder + "/log.md")
if (p && p.file.lists.length) dv.list(p.file.lists.slice(0, 5).map(l => l.text))
else dv.paragraph("_(no log entries)_")- h05 log
- strc
- h05
- Misha-specific PD: realistic affinity penalty 10-100× outside feasibility window; acoustic therapy = free adjunct → STRC Ca Oscillation Maternal-Only PD
- No tier change; stays A. Next: SPR/BLI E1659A affinity penalty measurement.
evidence
- STRC Calcium Oscillation Acoustic Therapy — main hypothesis; Phases 1-3 complete
- STRC AC1-CREB Alternative Hypothesis — AC1-CREB pivot from RBM24 path
- STRC Ca Oscillation Maternal-Only PD — Misha-specific PD: rescue only at penalty ≤3× and fold ≥1.3×
scripts
models/ (legacy pool — see STRC Computational Scripts Inventory § Hypothesis 5)
ca_oscillation_rbm24_ode.py,ca_oscillation_ac1_creb_pivot.pyca_oscillation_phase2_sensitivity.py,ca_oscillation_phase3_bifurcation.pyca_osc_maternal_allele_only.py
log
cross
- STRC mRNA Therapy Hypothesis — h06 Strategy A shares RBM24 regulatory context
- STRC Mini-STRC Single-Vector Hypothesis — h03 is primary; acoustic therapy is free adjunct regardless
Connections
[part-of]STRC Hypothesis Ranking[about]Misha